Blog - Page 3079 of 5753

MondayJun 03, 2013 1:33 pm

GlobalWise Investments, Inc. (GWIV) and The Future Of The Cloud

Cloud technology has exploded upon the world relatively recently, being increasingly accepted as a fundamental shift in the way that the power of computer processing and associated communications can be used. Various forms of cloud processing have begun to work their way into almost every industry, making it hard to consider the notion, also being increasingly accepted, that the term “cloud computing” could, in the not too distant future, effectively vanish. The disappearance of the term may or may not actually happen, but there seems to be little doubt that processing power and processed data will eventually become so completely…

MondayJun 03, 2013 10:14 am

The Vital Diversity of Cardium Therapeutics (CXM)

The length of time and associated costs involved in the development of important therapeutic medicines can put a serious strain on funding resources. In the case of Cardium Therapeutics and their one-of-a-kind DNA-based angiogenic growth factor therapeutic, Generx, being developed for the treatment of patients with advanced coronary artery disease, rather than depending upon outside direct funding sources, the company recognized that it was vital to have a long-term reliable income strategy. Cardium has chosen to diversify, providing layers of short-term and long-term support for their ongoing research, while building a broad marketplace presence. • Generx – Generx (alferminogene tadenovec,…

MondayJun 03, 2013 9:55 am

iTalk, Inc. (TALK) Acquires Vanity Toll Free Telephone Number, Relative Domains – Outlines Advantages

iTalk, a global provider of advanced communications and mobile broadband services, has acquired the vanity toll free telephone number 1-800-GET-VOIP, as well as five related domains: 1800GetVoIP.com, 1-800-Get-VoIP.com, 800GetVoIP.com, 800-Get-VoIP.com, and GetVoip.TV. "We are very pleased to have quickly completed the acquisition of the 1-800-GET-VOIP brand and domain assets to utilize for the promotion and marketing of a new retailiTalk Voice-over-IP subscriber-based telephone service to be launched in the U.S., Canada, and eventually throughout the world. We envision that, with a successful marketing campaign, 1-800-GET-VOIP will become the first dominant brand name synonymous with global VoIP services," David F. Levy,…

MondayJun 03, 2013 9:46 am

Xplore Technologies Corp. (XPLR) Wins 2013 Supply & Demand Chain 100 Award From SDCE Magazine For Ruggedized Tablet Deployment

Xplore Technologies, widely known for their extremely robust iX104C5 series of ruggedized, powerful, and long-lasting tablet PCs, was most pleased to announce to markets the reception of the Supply & Demand Chain Executive's (SDCE) coveted Supply & Demand Chain 100 Award for 2013 today, as XPLR has done a superb job of cutting costs and improving efficiency in the supply chain industry, leading to handsome ROI upside for one customer in particular. In partnership with S3Edge's amazing tablet-centric software that let the client drastically improve product management and shipping through a reduction in time and expense, as well as by…

MondayJun 03, 2013 9:46 am

Xplore Technologies Corp. (XPLR) Wins 2013 Supply & Demand Chain 100 Award From SDCE Magazine For Ruggedized Tablet Deployment

MondayJun 03, 2013 9:16 am

Jones Soda Co. and FIAT Partner for Summer Photo Contest to Promote New Products

Leading premium beverage company, Jones Soda Co. (OTCBB: JSDA), announced today that it has joined with the FIAT Brand to host a summer photo contest, "Jonesin' for a Fiat 500e.” The contest is part of a larger integrated marketing campaign for Jones Soda and the FIAT Brand to celebrate their new products: Natural Jones Soda and the automobile company's all-new, all-electric Fiat 500e. Both products will be launched exclusively in California later this year. "The sense of excitement that surrounds the launch of the Fiat 500e in California this summer creates a perfect opportunity for us to partner with like-minded…

FridayMay 31, 2013 5:12 pm

Curis, Inc. (CRIS), appoints Mani Mohindru, Ph.D., as Vice President of Corporate Strategy and Investor Relations

Oncology based company, Curis, Inc. (CRIS), announced earlier today the appointment of Dr. Mani Mohindru as Vice President of Corporate Strategy and Investor Relations. Dr. Mohindru, recruited for her expertise and experience supporting development and corporate strategy will direct product strategy, corporate development, investor relations and corporate communications. Curis, Inc. currently seeks to both develop and commercialize next generation targeted drug candidates for cancer treatment purposes. "Dr. Mohindru brings to Curis a strong and unique understanding of cancer drug markets and development strategies due to her wealth of experience in the analysis of the biotechnology sector," stated Mike Gray, Curis…

FridayMay 31, 2013 5:11 pm

FAB Universal Announces Kiosk Advertising Agreement with Shanghai Qiujia Culture Media

FAB Universal (FU), a distributor of digital entertainment across the globe, announced today that it has reached an advertising agreement with Shanghai Qiujia Culture Media to provide advertising on the top screen of the FAB Intelligent Media Kiosk Network. Annual revenue over the course of this five year, non-exclusive agreement is anticipated to equal over $1.6 million. Shanghai Qiujia Media is an outdoor media company engaging in advertisement design, production, and distribution. Quijia Media operates interactive media advertising, while simultaneously serving as an Information Network system equipment supplier. In 2008, Qiujia Media worked alongside Shanghai Transport Investment Corporation in the…

FridayMay 31, 2013 12:50 pm

Rafarma Pharmaceuticals, Inc. (RAFA) and Big Pharma

It’s almost impossible to talk about the economy and living standards without eventually getting caught up in a sometimes polarizing discussion about the high cost of healthcare. Spending for healthcare, as a percentage of GDP, has grown almost everywhere in the world, including the United States. Public resentment remains understandably high in this country as the pharmaceutical industry becomes bigger and more influential, generating a sense that the largest players are starting to depend more on marketing and lobbying than on visionary research. If Americans are reeling under the onslaught of high drug prices, it’s a feeling shared around the…

FridayMay 31, 2013 12:46 pm

VistaGen Therapeutics, Inc. (VSTA) and The Small Molecule

In the challenging world of drug development and production, one of the first factors to be considered is whether a drug will be a small molecule or big molecule drug. Big molecule drugs are often called simply biologics, although other terms are sometimes used for certain types of big molecule drugs. They are therapeutic drugs produced using biological processes, engineered from a living organism, and can be made up of complex proteins, nucleic acids, or even living cells. They’re useful in treating certain types of problems, but also have significant limitations, such as the fact that they can almost never…

Site Search

Company Search

GlobalWise Investments, Inc. (GWIV) and The Future Of The Cloud

The Vital Diversity of Cardium Therapeutics (CXM)

iTalk, Inc. (TALK) Acquires Vanity Toll Free Telephone Number, Relative Domains – Outlines Advantages

Xplore Technologies Corp. (XPLR) Wins 2013 Supply & Demand Chain 100 Award From SDCE Magazine For Ruggedized Tablet Deployment

Xplore Technologies Corp. (XPLR) Wins 2013 Supply & Demand Chain 100 Award From SDCE Magazine For Ruggedized Tablet Deployment

Jones Soda Co. and FIAT Partner for Summer Photo Contest to Promote New Products

Curis, Inc. (CRIS), appoints Mani Mohindru, Ph.D., as Vice President of Corporate Strategy and Investor Relations

FAB Universal Announces Kiosk Advertising Agreement with Shanghai Qiujia Culture Media

Rafarma Pharmaceuticals, Inc. (RAFA) and Big Pharma

VistaGen Therapeutics, Inc. (VSTA) and The Small Molecule

Market Basics

Newsletter Publishers

Public Companies